177 related articles for article (PubMed ID: 33410272)
1. Performance evaluation of stool DNA methylation tests in colorectal cancer screening: a systematic review and meta-analysis.
Gachabayov M; Lebovics E; Rojas A; Felsenreich DM; Latifi R; Bergamaschi R
Colorectal Dis; 2021 May; 23(5):1030-1042. PubMed ID: 33410272
[TBL] [Abstract][Full Text] [Related]
2. Early detection of colorectal cancer based on presence of methylated syndecan-2 (SDC2) in stool DNA.
Han YD; Oh TJ; Chung TH; Jang HW; Kim YN; An S; Kim NK
Clin Epigenetics; 2019 Mar; 11(1):51. PubMed ID: 30876480
[TBL] [Abstract][Full Text] [Related]
3. Accuracy of early detection of colorectal tumours by stool methylation markers: a meta-analysis.
Zhang H; Qi J; Wu YQ; Zhang P; Jiang J; Wang QX; Zhu YQ
World J Gastroenterol; 2014 Oct; 20(38):14040-50. PubMed ID: 25320544
[TBL] [Abstract][Full Text] [Related]
4. A novel method for early detection of colorectal cancer based on detection of methylation of two fragments of syndecan-2 (SDC2) in stool DNA.
Ma L; Qin G; Gai F; Jiang Y; Huang Z; Yang H; Yao S; Du S; Cao Y
BMC Gastroenterol; 2022 Apr; 22(1):191. PubMed ID: 35436855
[TBL] [Abstract][Full Text] [Related]
5. Feasibility of quantifying
Oh TJ; Oh HI; Seo YY; Jeong D; Kim C; Kang HW; Han YD; Chung HC; Kim NK; An S
Clin Epigenetics; 2017; 9():126. PubMed ID: 29225717
[TBL] [Abstract][Full Text] [Related]
6. Robust performance of a novel stool DNA test of methylated SDC2 for colorectal cancer detection: a multicenter clinical study.
Wang J; Liu S; Wang H; Zheng L; Zhou C; Li G; Huang R; Wang H; Li C; Fan X; Fu X; Wang X; Guo H; Guan J; Sun Y; Song X; Li Z; Mu D; Sun J; Liu X; Qi Y; Niu F; Chen C; Wu X; Wang X; Song X; Zou H
Clin Epigenetics; 2020 Oct; 12(1):162. PubMed ID: 33126908
[TBL] [Abstract][Full Text] [Related]
7. A systematic evaluation of stool DNA preparation protocols for colorectal cancer screening via analysis of DNA methylation biomarkers.
Jin S; Ye Q; Hong Y; Dai W; Zhang C; Liu W; Guo Y; Zhu D; Zhang Z; Chen S; Wang Y; Li D; Ma W; Yang Z; Li J; Zheng Z; Luan J; Wu X; Jiang F; Xu C; Ding C
Clin Chem Lab Med; 2020 Jul; 59(1):91-99. PubMed ID: 32673280
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of aberrant gene methylation in stool samples for colorectal cancer or adenomas: a meta-analysis.
Yuan Y; Qu B; Yan J; Wang H; Yin L; Han Q
Panminerva Med; 2015 Jun; 57(2):55-64. PubMed ID: 25256821
[TBL] [Abstract][Full Text] [Related]
9. Colorectal cancer screening using a stool DNA-based SDC2 methylation test: a multicenter, prospective trial.
Kim CW; Kim H; Kim HR; Kye BH; Kim HJ; Min BS; Oh TJ; An S; Lee SH
BMC Gastroenterol; 2021 Apr; 21(1):173. PubMed ID: 33858326
[TBL] [Abstract][Full Text] [Related]
10. A novel panel of stool-based DNA biomarkers for early screening of colorectal neoplasms in a Chinese population.
Sun M; Liu J; Hu H; Guo P; Shan Z; Yang H; Wang J; Xiao W; Zhou X
J Cancer Res Clin Oncol; 2019 Oct; 145(10):2423-2432. PubMed ID: 31456088
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of combined detection of multigene mutation and SDC2/SFRP2 methylation in stool specimens for colorectal cancer early diagnosis.
Lin J; Zhang L; Chen M; Chen J; Wu Y; Wang T; Lu Y; Ba Z; Cheng X; Xu R; Tian T; Sun A; Zhang T; Chen M
Int J Colorectal Dis; 2022 Jun; 37(6):1231-1238. PubMed ID: 35499710
[TBL] [Abstract][Full Text] [Related]
12. The importance of stool DNA methylation in colorectal cancer diagnosis: A meta-analysis.
Mojtabanezhad Shariatpanahi A; Yassi M; Nouraie M; Sahebkar A; Varshoee Tabrizi F; Kerachian MA
PLoS One; 2018; 13(7):e0200735. PubMed ID: 30024936
[TBL] [Abstract][Full Text] [Related]
13. Detection of hypermethylated fibrillin-1 in the stool samples of colorectal cancer patients.
Guo Q; Song Y; Zhang H; Wu X; Xia P; Dang C
Med Oncol; 2013 Dec; 30(4):695. PubMed ID: 23963856
[TBL] [Abstract][Full Text] [Related]
14. Combined detection of SDC2/ADHFE1/PPP2R5C methylation in stool DNA for colorectal cancer screening.
Li B; Liu S; Gao Y; Zheng L; Lu Y
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10241-10253. PubMed ID: 37270460
[TBL] [Abstract][Full Text] [Related]
15. [Application study of stool-based methylated SDC2 test in the screening of colorectal neoplasms for physical examination population].
Wang L; Huang ZM; Jiang YY; Zhu M; Zhang N; Xiong FB; Zou HZ; Xu XH
Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Dec; 56(12):1767-1773. PubMed ID: 36536564
[No Abstract] [Full Text] [Related]
16. Significance of SDC2 and NDRG4 methylation in stool for colorectal cancer diagnosis.
Long L; Sun Q; Yang F; Zhou H; Wang Y; Xiao C; He Q; Yi B
Clin Biochem; 2024 Feb; 124():110717. PubMed ID: 38224931
[TBL] [Abstract][Full Text] [Related]
17. Novel methylation panel for the early detection of colorectal tumors in stool DNA.
Azuara D; Rodriguez-Moranta F; de Oca J; Soriano-Izquierdo A; Mora J; Guardiola J; Biondo S; Blanco I; Peinado MA; Moreno V; Esteller M; Capellá G
Clin Colorectal Cancer; 2010 Jul; 9(3):168-76. PubMed ID: 20643622
[TBL] [Abstract][Full Text] [Related]
18. Stool-based DNA testing, a new noninvasive method for colorectal cancer screening, the first report from Iran.
Abbaszadegan MR; Tavasoli A; Velayati A; Sima HR; Vosooghinia H; Farzadnia M; Asadzedeh H; Gholamin M; Dadkhah E; Aarabi A
World J Gastroenterol; 2007 Mar; 13(10):1528-33. PubMed ID: 17461444
[TBL] [Abstract][Full Text] [Related]
19. Analytical sensitivity and stability of DNA methylation testing in stool samples for colorectal cancer detection.
Bosch LJ; Mongera S; Terhaar Sive Droste JS; Oort FA; van Turenhout ST; Penning MT; Louwagie J; Mulder CJ; van Engeland M; Carvalho B; Meijer GA
Cell Oncol (Dordr); 2012 Aug; 35(4):309-15. PubMed ID: 22821210
[TBL] [Abstract][Full Text] [Related]
20. Aberrant methylation of genes in stool samples as diagnostic biomarkers for colorectal cancer or adenomas: a meta-analysis.
Luo YX; Chen DK; Song SX; Wang L; Wang JP
Int J Clin Pract; 2011 Dec; 65(12):1313-20. PubMed ID: 22093539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]